Triple

T9806869
Position Surface form Disambiguated ID Type / Status
Subject Chugai Pharmaceutical E238175 entity
Predicate hasSubsidiary P254 FINISHED
Object Chugai Pharma USA
Chugai Pharma USA is the U.S.-based subsidiary of Chugai Pharmaceutical, focused on developing and commercializing innovative pharmaceutical products in the American market.
 E238175 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Chugai Pharma USA | Statement: [Chugai Pharmaceutical, hasSubsidiary, Chugai Pharma USA]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Chugai Pharma USA
Context triple: [Chugai Pharmaceutical, hasSubsidiary, Chugai Pharma USA]
  • A. Chugai Pharmaceutical
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • B. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • C. Eisai
    Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
  • D. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • E. Mitsubishi Tanabe Pharma
    Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Chugai Pharma USA
Triple: [Chugai Pharmaceutical, hasSubsidiary, Chugai Pharma USA]
Generated description
Chugai Pharma USA is the U.S.-based subsidiary of Chugai Pharmaceutical, focused on developing and commercializing innovative pharmaceutical products in the American market.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Chugai Pharma USA
Target entity description: Chugai Pharma USA is the U.S.-based subsidiary of Chugai Pharmaceutical, focused on developing and commercializing innovative pharmaceutical products in the American market.
  • A. Chugai Pharmaceutical chosen
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • B. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • C. Eisai
    Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
  • D. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • E. Mitsubishi Tanabe Pharma
    Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ca84defac48190abc1148804f184c1 completed March 30, 2026, 2:12 p.m.
NER Named-entity recognition batch_69cdab7cb9588190953a063cb7b9e29e completed April 1, 2026, 11:34 p.m.
NED1 Entity disambiguation (via context triple) batch_69d1cc57119881909616d835def02fc9 completed April 5, 2026, 2:43 a.m.
NEDg Description generation batch_69d1cd137b30819089356b9fbc265d17 completed April 5, 2026, 2:46 a.m.
NED2 Entity disambiguation (via description) batch_69d1cd8fcf488190bc72a99e81fb618b completed April 5, 2026, 2:48 a.m.
Created at: March 30, 2026, 8:29 p.m.